Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic lung allograft dysfunction phenotypes and treatment.

Stijn E Verleden1, Robin Vos1, Bart M Vanaudenaerde1

  • 1Department of Clinical and Experimental Medicine, Lung Transplant Unit, KU Leuven, Leuven, Belgium.

Journal of Thoracic Disease
|September 22, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alveolar niche disruption and aberrant epithelial reprogramming are early hallmarks of idiopathic pulmonary fibrosis.

bioRxiv : the preprint server for biology·2026
Same author

A Transcriptomic Atlas of Chronic Lung Allograft Dysfunction.

The European respiratory journal·2026
Same author

Blood vessels as primary site of rejection in murine lung transplantation.

Transplant international : official journal of the European Society for Organ Transplantation·2026
Same author

A Perspective Summary of the ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD).

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Three-dimensional micro-CT analysis of vascular remodeling and vascular pruning in pulmonary arterial hypertension.

The European respiratory journal·2026
Same author

ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD): Definition, Etiology, Diagnostic and Therapeutic Approaches, and Research Priorities.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same journal

From contraindication to consideration: the role of esophagectomy in stage IV esophageal adenocarcinoma.

Journal of thoracic disease·2026
Same journal

Clinical features and prognostic factor of small (≤2 cm) lung cancer associated with cystic airspaces.

Journal of thoracic disease·2026
Same journal

Sex-specific trends in incidence and mortality of interstitial lung disease and pulmonary sarcoidosis in China compared with global estimates, 1990-2023: an analysis of GBD 2023.

Journal of thoracic disease·2026
Same journal

A single-arm, single-center phase II clinical study of concurrent brain radiotherapy combined with tislelizumab and chemotherapy in patients with small-cell lung cancer and brain metastases.

Journal of thoracic disease·2026
Same journal

Minimally invasive off-pump coronary artery bypass grafting is associated with reduced postoperative intra-aortic balloon pump use.

Journal of thoracic disease·2026
Same journal

Pulmonary artery involvement contributes to the recurrence of hemoptysis after bronchial artery embolization in patients with chronic pulmonary aspergillosis.

Journal of thoracic disease·2026
See all related articles

Chronic lung allograft dysfunction (CLAD) presents two distinct phenotypes: bronchiolitis obliterans syndrome (BOS) and restrictive CLAD (rCLAD). Differentiating these phenotypes is crucial for understanding prognosis and guiding treatment in lung transplant recipients.

Area of Science:

  • Pulmonology
  • Transplantation Immunology
  • Pathology

Background:

  • Chronic lung allograft dysfunction (CLAD) significantly impacts long-term survival after lung transplantation.
  • CLAD exhibits clinical heterogeneity, leading to the recent definition of two distinct phenotypes: bronchiolitis obliterans syndrome (BOS) and restrictive CLAD (rCLAD).

Purpose of the Study:

  • To review the historical evidence supporting CLAD heterogeneity.
  • To highlight the distinct clinical, radiological, and histopathological characteristics of BOS and rCLAD.
  • To discuss risk factors and current treatment strategies for CLAD phenotypes.

Main Methods:

  • Literature review of historical evidence for CLAD heterogeneity.
  • Analysis of clinical presentation, radiological findings (CT scans), and histopathological features (biopsies) for BOS and rCLAD.
Keywords:
Lung transplantationbronchiolitis obliterans syndrome (BOS)chronic lung allograft dysfunction (CLAD)chronic rejectionrestrictive allograft syndrome (RAS)

Related Experiment Videos

  • Overview of treatment strategies and their outcomes.

    • Main Results:

    • BOS is characterized by obstructive physiology, air trapping, and obliterative bronchiolitis.
    • RAS/rCLAD presents with restrictive physiology, pleuro-parenchymal infiltrates, and fibro-elastosis, associated with poorer survival (6-18 months vs. 3-5 years for BOS).
    • Effective phenotyping is challenging but essential for clinical management and research.

    Conclusions:

    • Recognizing the distinct phenotypes of CLAD (BOS vs. rCLAD) is critical for accurate diagnosis and prognosis.
    • Further research and improved phenotyping methods are needed to optimize treatment strategies for CLAD.
    • Understanding CLAD heterogeneity is vital for improving long-term outcomes in lung transplant recipients.